Parmax Pharma Ltd — Important, 01-01-1970: Company Update

Parmax Pharma Limited's acquirers have completed the post-offer advertisement for their open offer to acquire up to 23.46 lakh equity shares. This represents 26.00% of the company's expanded voting share capital, with each share having a face value of ₹10. This announcement confirms the formal advertising phase completion of the open offer, which is significant for public shareholders regarding potential changes in ownership and control.